1. Mathewson, Nathan D, Ashenberg, Orr, Tirosh, Itay, Suvà, Mario L, Wucherpfennig, Kai W. 2021. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. In Cell, 184, 1281-1298.e26. doi:10.1016/j.cell.2021.01.022. https://pubmed.ncbi.nlm.nih.gov/33592174/
2. Alvarez Calderon, Francesca, Kang, Byong H, Kyrysyuk, Oleksandr, Wittrup, K Dane, Wucherpfennig, Kai W. . Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignancies. In Blood, 143, 1124-1138. doi:10.1182/blood.2023022882. https://pubmed.ncbi.nlm.nih.gov/38153903/
3. El-Fadeal, Noha M Abd, Saad, Manar A, Mehanna, Eman T, Abo-Elmatty, Dina M, Hosny, Nora. 2024. Association of CIITA (rs8048002) and CLEC2D (rs2114870) gene variants and type 1 diabetes mellitus. In Journal of diabetes and metabolic disorders, 23, 1151-1162. doi:10.1007/s40200-024-01402-w. https://pubmed.ncbi.nlm.nih.gov/38932894/
4. Germain, Claire, Bihl, Franck, Zahn, Stefan, Spee, Pieter, Braud, Veronique M. 2010. Characterization of alternatively spliced transcript variants of CLEC2D gene. In The Journal of biological chemistry, 285, 36207-15. doi:10.1074/jbc.M110.179622. https://pubmed.ncbi.nlm.nih.gov/20843815/
5. Bouzid, Dorra, Fourati, Hajer, Amouri, Ali, Penha-Gonçalves, Carlos, Masmoudi, Hatem. 2013. Association of ZAP70 and PTPN6, but Not BANK1 or CLEC2D, with inflammatory bowel disease in the Tunisian population. In Genetic testing and molecular biomarkers, 17, 321-6. doi:10.1089/gtmb.2012.0372. https://pubmed.ncbi.nlm.nih.gov/23406209/
6. Sanchez-Canteli, Mario, Hermida-Prado, Francisco, Sordo-Bahamonde, Christian, García-Pedrero, Juana M, Rodrigo, Juan P. 2020. Lectin-Like Transcript 1 (LLT1) Checkpoint: A Novel Independent Prognostic Factor in HPV-Negative Oropharyngeal Squamous Cell Carcinoma. In Biomedicines, 8, . doi:10.3390/biomedicines8120535. https://pubmed.ncbi.nlm.nih.gov/33255617/
智鼠故事 
